LIHC Safer Opioid Supply Program September 2023 Evaluation Report: A Comparison of SOS Client Outcomes from 2022 and 2023: This evaluation reports on client outcomes from the LIHC SOS program using self-reported survey data collected in spring of 2022 and again in spring of 2023 from clients of the SOS program. It is a follow-up to the first SOS program evaluation conducted in 2021.
Characteristics of Substance-Related Toxicity Deaths in Ontario: Stimulant, opioid, benzodiazepine, and alcohol-related deaths – ODPRN: This joint report by the ODPRN and Public Health Ontario provides an overview on the trends and patterns of single and polysubstance (more than one substance) deaths from alcohol, benzodiazepines, opioids, and stimulants in Ontario (January 1, 2018 to December 31, 2021).
Prescribed Safer Supply Protocols: Sufentanil – BCCSU and PHS: These resources provide a standardized protocol for the provision of sufentanil as a way to reduce reliance on the unregulated drug supply and associated harms. This protocol is adapted from PHS Community Services Society’s Sufentanil Policy.
Prescribed Safer Supply Protocols: Fentanyl Tablet – BCCSU and PHS: These resources provide a standardized protocol for the provision of fentanyl tablets as a way to reduce reliance on the unregulated drug supply and associated harms. This protocol is adapted from PHS Community Services Society’s Fentanyl Tablet Policy.
MySafe safer opioid supply program using biometric dispensing machines – CATIE Programming Connection: MySafe is a safer opioid supply program for individuals at high risk of overdose from consumption of illegal opioids. It uses secure biometric dispensing machines to provide daily doses of physician-prescribed opioids in the form of hydromorphone tablets. A qualitative study identified participant-reported facilitators, barriers and outcomes. Facilitators included non-witnessed use, ease of access and policies that allowed participants to plan and adapt their use. Barriers included technical issues and issues related to insufficient doses and potency. Outcomes included reduced illegal drug use, decreased overdose risk and improved health and well-being for participants.
A Public Health Approach to Substance Use Handbook – Canadian Public Health Association: This handbook can be used alone as a self-guided workbook, or in a small group with or without facilitation. It can support self-reflection, community coordination, and the important cross-agency and system-wide conversations about how to widen and improve the response to substance use. It can also inspire respectful and destigmatizing conversations with people who use substances and engage with peer support networks.
A Guide to Using Extended-Release Buprenorphine (Sublocade®) in Opioid Agonist Therapy (OAT) - ESCODI: The Équipe de soutien clinique et organisationnel en dépendance et itinérance (ESCODI) in Montréal recently published a guide to using extended-release buprenorphine (Sublocade®) in OAT. The NSS-CoP is pleased to be sharing the English translation of their new publication. Read and download it now!